Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 7Hodgkin Disease 6Lymphoma, Large B-Cell, Diffuse 5Triple Negative Breast Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 4Rhabdomyosarcoma 3Lymphoma, Non-Hodgkin 3Leukemia 3Burkitt Lymphoma 3Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Neuroblastoma 2Multiple Myeloma 2Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Teratoma 1Squamous Cell Carcinoma of Head and Neck 1Sleep Initiation and Maintenance Disorders 1Sarcoma, Ewing 1Renal Pelvis and Ureter Urothelial Carcinoma 1Recurrence 1Prostatic Neoplasms 1Pheochromocytoma 1Pancreatic Neoplasms 1Pain 1

Interventions

Methotrexate 6Cyclophosphamide 6ponatinib 5Cytarabine 5merphos 4Mycophenolic Acid 4blinatumomab 3Whole-Body Irradiation 3Tacrolimus 3Peripheral Blood Stem Cell Transplantation 3Cyclosporine 3venetoclax 2fludarabine phosphate 2bosutinib 2Vincristine 2Rituximab 2N,N-dicyclohexyl-isoborneol-10-sulfonamide 2Idarubicin 2Etoposide 2Cladribine 2CT-P10 2Busulfan 2prednylidene 1pegfilgrastim 1nilotinib 1midostaurin 1gilteritinib 1fludarabine 1dexamethasone acetate 1dexamethasone 21-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Blast Crisis × pegfilgrastim × 1 year × Clear all
NCT03147612 2026-02-17

Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
22 enrolled
LymphoidOther hematologic neoplasm

Blast Crisis, Leukemia, Myeloid, Accelerated Phase, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡